Participating in research is one of the most powerful things you can do to be part of tomorrow's healthcare breakthroughs. Penn State Health is always looking for people who are willing to participate in studies, so that our researchers can better understand how to diagnose, treat, and prevent diseases and conditions.
The study will evaluate the effect of treatment with omecamtiv mecarbil compared with placebo on exercise capacity as determined by cardiopulmonary exercise testing following 20 weeks of treatment with omecamtiv...
The study is looking to find out more about how an investigational study drug called omecamtiv mecarbil works in people with heart failure. Omecamtiv mecarbil is also known as AMG...
The purpose of this study is to evaluate the safety and effectiveness of renal denervation while still on blood pressure medications. Renal denervation is the destruction of nerve fibers that...
To determine if the drug Amiloride will reduce exercise related muscle pain and improve exercise tolerance in healthy volunteers....
The dal-GenE trial is evaluating the potential of dalcetrapib to reduce cardiovascular morbidity and mortality in patients with a documented recent heart attack or hospitalization due to severe coronary artery...
This research is being conducted to determine how oxygen extraction within exercising muscles is altered in younger and older women when beta-1 receptors (receptors that contribute to the rise in...
We will investigate the effects of the hormone angiotensin-(1-7) on energy expenditure in patients with obesity....
Personal narratives or storytelling is an approach that has been used to promote healthy behaviors among people with diabetes, breast cancer, and high blood pressure. There is a need for...
这个项目的目标是了解续ribution of depression on blood vessel function in post-menopausal women, a population at heightened risk for cardiovascular disease. Currently, little is...
This study is looking at how blood pressure control is altered by increased volume in veins....
